About

Jeffrey Schwaneke has served as agilon health's Chief Financial Officer since July 2024 and as co-Interim Principal Executive Officer since July 2025, as part of the Office of the Chairman. He previously served as a member of agilon's Board of Directors from 2022 to 2024. Before joining agilon, Mr. Schwaneke spent more than a decade at Centene Corporation, where he served as Executive Vice President of Health Care Enterprises in 2021 and as Executive Vice President, Chief Financial Officer and Treasurer from 2016 to 2021, having joined Centene in 2008 as Senior Vice President, Corporate Controller and Chief Accounting Officer. Earlier he was Assistant Controller and then Chief Accounting Officer of Novelis, Inc. He holds a B.S. in Accounting from the University of Missouri and is a CPA.

Roles

agilon health, inc.
Chief Financial Officer and Interim Co-Principal Executive Officer · Current role
2024–present
agilon health, inc.
Member of the Board of Directors
2022–2024
Centene Corporation
Executive Vice President of Health Care Enterprises · June to September 2021
Centene Corporation
Executive Vice President, Chief Financial Officer and Treasurer · March 2016 to May 2021
2016–2021
Centene Corporation
Senior Vice President, Corporate Controller and Chief Accounting Officer · Joined July 2008
Novelis, Inc.
Assistant Controller; then Chief Accounting Officer
2006–2008
SPX
Senior finance position
PwC (Price Waterhouse)
Senior finance position

Fixed Compensation

FY 2025
Base salary
$625,000
ComponentAnnual base salary
All other compensation
$14,000
IncludesIncludes a $300,000 signing bonus in 2024 (none in 2025)
Total compensation
$5,610,878

Performance Compensation

Data from FY 2025

Cash incentive

Annual cash incentive
$271,875
FormNon-Equity Incentive Plan Compensation

Stock awards

Stock awards
$2,950,003
FormRSUs and PSUs (grant date fair value, ASC 718)
Option awards
$1,750,000
FormStock options

Also at agilon health, inc.

Related

See how VectorShift works for your firm

Request Demo